missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Melanoma Discriminated Antigen Monoclonal Antibody (PAL-M1)
Mouse Monoclonal Antibody
Brand: Invitrogen™ MA135614
This item is not returnable.
View return policy
Description
Antibody PAL-M1 stains the majority of primary melanomas and the large majority of metastases and is directed against the transferrin receptor (CD71). Local staining of dysplastic nevocellular nevi may be observed. Common nevocellular nevi rarely stain.
Melanoma is a malignant tumor of melanocytes which are found predominantly in skin but also in the bowel and the eye (see uveal melanoma). It is one of the rarer types of skin cancer but causes the majority of skin cancer related deaths. Despite many years of intensive laboratory and clinical research, the sole effective cure is surgical resection of the primary tumor before it achieves a thickness of greater than 1 mm.
Specifications
| Melanoma Discriminated Antigen | |
| Monoclonal | |
| Conc. Not Determined | |
| tissue culture supernatant with 10mM sodium azide | |
| Mouse | |
| 1 mL | |
| Primary | |
| 4°C | |
| Liquid |
| Flow Cytometry, Immunohistochemistry (Frozen), Western Blot | |
| PAL-M1 | |
| Unconjugated | |
| melanoma antigen; melanoma associated antigen | |
| Human melanoma metastases tissue. | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction